Cohort | AUC | MAE* | MAPE* | RMSE* | R2 | |
---|---|---|---|---|---|---|
Discovery cohort (CAPOC, n = 2307) | ||||||
APD | All | 0.874 | 0.209 | 1.332 | 0.272 | 0.478 |
Aripiprazole | 0.882 | 0.220 | 1.203 | 0.290 | 0.481 | |
Haloperidol | 0.850 | 0.179 | 2.243 | 0.236 | 0.501 | |
Olanzapine | 0.878 | 0.180 | 1.644 | 0.239 | 0.510 | |
Perphenazine | 0.901 | 0.211 | 1.185 | 0.267 | 0.517 | |
Quetiapine | 0.856 | 0.241 | 1.081 | 0.305 | 0.392 | |
Risperidone | 0.892 | 0.181 | 1.089 | 0.239 | 0.521 | |
Ziprasidone | 0.865 | 0.235 | 1.291 | 0.299 | 0.414 | |
Sex | Male | 0.875 | 0.196 | 1.316 | 0.256 | 0.536 |
Female | 0.880 | 0.221 | 1.347 | 0.287 | 0.418 | |
Validation cohort (CAPEC, n = 1379) | ||||||
APD | All | 0.851 | 0.154 | 1.470 | 0.205 | 0.507 |
Aripiprazole | 0.882 | 0.151 | 1.114 | 0.195 | 0.564 | |
Olanzapine | 0.840 | 0.155 | 1.628 | 0.208 | 0.468 | |
Risperidone | 0.831 | 0.155 | 1.671 | 0.212 | 0.484 | |
Sex | Male | 0.843 | 0.151 | 1.926 | 0.205 | 0.500 |
Female | 0.860 | 0.156 | 1.043 | 0.205 | 0.513 |